All blog items

A research team led by the Duke Cancer Institute has identified the mechanisms at work, describing how breast cancer cells use cholesterol to develop tolerance to stress, making them impervious to death as they migrate from the original tumor site.

Leaders in the School of Medicine’s Office of Biomedical Graduate Education have developed a new resource to provide incoming PhD students with social support as they begin their education.

As a lover of adventure, learning, and family time, David Theil, MD, is always looking for fun activities to do with his adult children, Jackie and Sam. Last year, they embarked on one of their greatest adventures yet when all three enrolled in Duke University School of Medicine’s Master of Management in Clinical Informatics (MMCi).

Our MS1 students have been off to a great start this year. They completed their orientation a couple weeks ago and have been able to meet other PCLT students and faculty. Welcome Madeline Brown, Allison Chu, Nicholas Hastings, Maame Amoako, Beau Blass, Danielle Levinson, Evlyn Samuel and Esme Trahair. We're also excited to welcome a new associate program director for pediatrics. Dr. Ellie Erickson recently stepped down from the role to pursue other opportunities and Dr. Naomi Duke recently took her place. Here's a message from Dr.

The award is given annually to an individual who has established an outstanding mycological career and is one of the highest awards bestowed by the MSA. Mycology is the branch of biology concerned with the study of fungi.

Research Community News iRIS/OnCore Updates DOCR News Recruitment Innovation Corner Did You Know? Training Opportunities Clinical Research Employee Highlights

Lauren Truby is a fellow in cardiovascular disease at Duke University Medical Center. She is the lead author of a new publication that uses proteomic profiling to identify a specific protein as a biomarker of primary graft dysfunction after a heart transplant.

An innovative study at Duke Health aims to determine the prevalence of COVID-related heart inflammation among top-level athletes and establish the symptoms and clinical features to ensure they receive timely and accurate diagnoses.

An investigational treatment pioneered by a Duke Health pediatrician resulted in a one-year survival rate of 77% among children born with a rare condition in which they lack an immune system. The treatment, using cultured thymus tissue (CTT), has been studied at Duke since 1993 for babies born without a thymus gland, which produces the all-important T cells that are key to fighting infections. Without treatment, babies born with the rare condition, called congenital athymia, are vulnerable to fatal infections and do not survive beyond early childhood.

The Duke University School of Medicine Office of Biomedical and Graduate Education (OBGE) and Precision Genomics Collaboratory awarded 10 pilot grants of $2,000 each to SOM Biomedical PhD students. The goal of these grants is to support our students in scientific and educational efforts to bolster their graduate training experiences. These awards will help further research in a broad array of topics including into diseases like Prader-Willi Syndrome, prostate cancer, rhabdomyosarcoma and influenza.